Li PK et al. |
The complications of newer transplant antirejection drugs: treatment with cyclosporin A, OKT3, and FK506. |
1990 |
Adverse Drug React Acute Poisoning Rev |
pmid:1703724
|
Todo S et al. |
Early trials with FK 506 as primary treatment in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689886
|
McCauley J et al. |
The effects of FK 506 on renal function after liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689887
|
Kang Y et al. |
Acute hemodynamic effects of FK 506 during and after orthotopic liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689889
|
Jain AB et al. |
FK 506 dosage in human organ transplantation. |
1990 |
Transplant. Proc. |
pmid:1689890
|
Demetris AJ et al. |
Pathologic observations in human allograft recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689891
|
Shapiro R et al. |
The side effects of FK 506 in humans. |
1990 |
Transplant. Proc. |
pmid:1689892
|
Van Thiel DH et al. |
Gastrointestinal and metabolic problems associated with immunosuppression with either CyA or FK 506 in liver transplantation. |
1990 |
Transplant. Proc. |
pmid:1689893
|
Mieles L et al. |
Oral glucose tolerance test in liver recipients treated with FK 506. |
1990 |
Transplant. Proc. |
pmid:1689894
|
Alessiani M et al. |
Infections with FK 506 immunosuppression: preliminary results with primary therapy. |
1990 |
Transplant. Proc. |
pmid:1689895
|
Woo J et al. |
The influence of FK-506 and low-concentration ciclosporin on human lymphocyte activation antigen expression and blastogenesis: a flow cytometric analysis. |
1990 |
Scand. J. Immunol. |
pmid:1690915
|
Yasunami Y et al. |
FK506 as the sole immunosuppressive agent for prolongation of islet allograft survival in the rat. |
1990 |
Transplantation |
pmid:1691535
|
Metcalfe SM and Richards FM |
Cyclosporine, FK506, and rapamycin. Some effects on early activation events in serum-free, mitogen-stimulated mouse spleen cells. |
1990 |
Transplantation |
pmid:1691537
|
Morimoto T et al. |
Pancreaticoduodenal allotransplantation with FK 506 in the dog. |
1990 |
Transplant. Proc. |
pmid:1691550
|
Yasunami Y et al. |
Characterization of the immunosuppressive activity of FK 506 in rat islet allografts. |
1990 |
Transplant. Proc. |
pmid:1691557
|
Thomson AW |
FK-506 enters the clinic. |
1990 |
Immunol. Today |
pmid:1692221
|
Saitoh Y et al. |
Morphological rejection phases and cytotoxic activity in peripheral blood lymphocytes in canine lung allo-transplantation. |
1990 |
Jpn J Surg |
pmid:1692892
|
Rosen MK et al. |
Inhibition of FKBP rotamase activity by immunosuppressant FK506: twisted amide surrogate. |
1990 |
Science |
pmid:1693013
|
Thomas FT et al. |
Comparative efficacy of immunosuppressive drugs in xenografting. |
1990 |
Transplant. Proc. |
pmid:1693452
|
Harrison RK and Stein RL |
Substrate specificities of the peptidyl prolyl cis-trans isomerase activities of cyclophilin and FK-506 binding protein: evidence for the existence of a family of distinct enzymes. |
1990 |
Biochemistry |
pmid:1693856
|
Justice RM et al. |
The detection of proline isomerase activity in FK506-binding protein by two-dimensional 1H NMR exchange spectroscopy. |
1990 |
Biochem. Biophys. Res. Commun. |
pmid:1697463
|
Todo S et al. |
Liver, kidney, and thoracic organ transplantation under FK 506. |
1990 |
Ann. Surg. |
pmid:1697743
|
Sakr MF et al. |
FK 506 ameliorates the hepatic injury associated with ischemia. |
1990 |
Life Sci. |
pmid:1698241
|
Kurasawa K et al. |
The immunosuppressant FK-506 prevents progression of diabetes in nonobese diabetic mice. |
1990 |
Clin. Immunol. Immunopathol. |
pmid:1698584
|
Miyagawa J et al. |
Preventive effect of a new immunosuppressant FK-506 on insulitis and diabetes in non-obese diabetic mice. |
1990 |
Diabetologia |
pmid:1698679
|
Lagodzinski Z et al. |
Effect of FK506 and cyclosporine on primary and secondary skin allograft survival in mice. |
1990 |
Immunology |
pmid:1698713
|
Kawashima H et al. |
Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat. |
1990 |
Invest. Ophthalmol. Vis. Sci. |
pmid:1702408
|
Wilkinson PC and Watson EA |
FK506 and pertussis toxin distinguish growth-induced locomotor activation from attractant-stimulated locomotion in human blood lymphocytes. |
1990 |
Immunology |
pmid:1702750
|
Metcalfe S and Milner J |
Phosphatases PP1 and PP2A act after the G0/G1 interface in lymphocyte activation. |
1990 |
Immunol. Lett. |
pmid:1702753
|
Takada K et al. |
Determination of a novel potent immunosuppressant (FK-506) in rat serum and lymph by high-performance liquid chromatography with chemiluminescence detection. |
1990 |
J. Chromatogr. |
pmid:1703552
|
Woo J et al. |
Antigen presentation and HLA-DR expression by FK-506-treated human monocytes. |
1990 |
Immunology |
pmid:1703987
|
Fung JJ et al. |
Overview of FK506 in transplantation. |
1990 |
Clin Transpl |
pmid:1715740
|
Pugh-Humphreys RG et al. |
The influence of FK-506 on the thymus: an immunophenotypic and structural analysis. |
1990 |
Immunology |
pmid:1696242
|
Collier SJ |
Immunosuppressive drugs. |
1989-1990 |
Curr. Opin. Immunol. |
pmid:2484794
|
McCauley J et al. |
Treatment of cyclosporin-induced haemolytic uraemic syndrome with FK506. |
1989 Dec 23-30 |
Lancet |
pmid:2481200
|
Sanghvi A et al. |
Increased cyclosporine uptake by cells pretreated with FK506 and evidence for binding of both drugs to a common intracellular protein. |
1989 |
Transplant. Proc. |
pmid:2468204
|
Takagishi K et al. |
Effects of FK-506 on collagen arthritis in mice. |
1989 |
Transplant. Proc. |
pmid:2468205
|
Arita C et al. |
Effect of FK 506 (FR 900506) on collagen arthritis in rats: a preliminary report. |
1989 |
Transplant. Proc. |
pmid:2468206
|
Morimoto T et al. |
Blood levels of FK506 after intramuscular and intravenous administration in dogs. |
1989 |
Transplant. Proc. |
pmid:2468207
|
Tsuchimoto S et al. |
Orthotopic liver transplantation in rats receiving FK506. |
1989 |
Transplant. Proc. |
pmid:2468208
|
Yokota K et al. |
Comparative studies of FK506 and cyclosporine in canine orthotopic hepatic allograft survival. |
1989 |
Transplant. Proc. |
pmid:2468209
|
Inagaki K et al. |
Effects of FK506 and 15-deoxyspergualin in rat orthotopic liver transplantation. |
1989 |
Transplant. Proc. |
pmid:2468210
|
Gudas VM et al. |
Comparison of the immunosuppressive and toxic effects of FK506 and cyclosporine in xenograft recipients. |
1989 |
Transplant. Proc. |
pmid:2468211
|
Sato K et al. |
Pancreaticoduodenal allotransplantation with cyclosporine and FK506. |
1989 |
Transplant. Proc. |
pmid:2468212
|
Watanabe K et al. |
Prolongation effect of a small dose of FK506, cyclosporine, or azathioprine on renal allografts in dogs treated with fractionated lymphoid irradiation and donor bone marrow cell infusion. |
1989 |
Transplant. Proc. |
pmid:2468213
|
Freedman RB |
Immunosuppression. Convergence of drug action. |
1989 |
Nature |
pmid:2477712
|
Siekierka JJ et al. |
A cytosolic binding protein for the immunosuppressant FK506 has peptidyl-prolyl isomerase activity but is distinct from cyclophilin. |
1989 |
Nature |
pmid:2477714
|
Harding MW et al. |
A receptor for the immunosuppressant FK506 is a cis-trans peptidyl-prolyl isomerase. |
1989 |
Nature |
pmid:2477715
|
Kay JE et al. |
The mechanism of action of the immunosuppressive drug FK-506. |
1989 |
Cell. Immunol. |
pmid:2478301
|
Starzl TE et al. |
FK 506 for liver, kidney, and pancreas transplantation. |
1989 |
Lancet |
pmid:2478846
|